Detalhe da pesquisa
1.
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Eur J Haematol
; 110(6): 696-705, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36919878
2.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37222267
3.
PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
G Ital Nefrol
; 39(1)2022 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35191627
4.
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.
Br J Haematol
; 174(1): 160-2, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26507357
5.
Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study.
Leuk Res
; 61: 10-17, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28846953
6.
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 16(2): 96-103, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26711180
7.
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia.
J Clin Pathol
; 65(10): 953-5, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22718845